Literature DB >> 1283750

Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients.

S Mercadante, S Maddaloni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283750     DOI: 10.1016/0885-3924(92)90137-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  3 in total

Review 1.  Palliative care.

Authors:  C L Davis; J R Hardy
Journal:  BMJ       Date:  1994-05-21

2.  Octreotide prevents the pathological alterations of bowel obstruction in cancer patients.

Authors:  S Mercadante; G Avola; S Maddaloni; G Salamone; F Aragona; V Rodolico
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

3.  Why not octreotide?

Authors:  S Mercadante
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.